Cargando…

MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor

Therapeutic resistance is a major obstacle to achieving durable clinical responses with targeted therapies, highlighting a need to elucidate the underlying mechanisms responsible for resistance and identify strategies to overcome this challenge. An emerging body of data implicates the tyrosine kinas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caenepeel, Sean, Cooke, Keegan, Wadsworth, Sarah, Huang, Guo, Robert, Lidia, Moreno, Blanca Homet, Parisi, Giulia, Cajulis, Elaina, Kendall, Richard, Beltran, Pedro, Ribas, Antoni, Coxon, Angela, Hughes, Paul E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392287/ https://www.ncbi.nlm.nih.gov/pubmed/28147313 http://dx.doi.org/10.18632/oncotarget.14855

Ejemplares similares

Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma
por: Homet Moreno, Blanca, et al.
Publicado: (2015)

Essential Role of Gab1 for Signaling by the C-Met Receptor in Vivo
por: Sachs, Martin, et al.
Publicado: (2000)

Coupling of Gab1 to C-Met, Grb2, and Shp2 Mediates Biological Responses
por: Schaeper, Ute, et al.
Publicado: (2000)

Met receptor tyrosine kinase signals through a cortactin–Gab1 scaffold complex, to mediate invadopodia
por: Rajadurai, Charles V., et al.
Publicado: (2012)

HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer
por: Fan, Gaofeng, et al.
Publicado: (2016)

The Role of GAB1 in Cancer
por: Pérez-Baena, Manuel Jesús, et al.
Publicado: (2023)

Anti-c-MET Fab-Grb2-Gab1 Fusion Protein-Mediated Interference of c-MET Signaling Pathway Induces Methuosis in Tumor Cells
por: Dou, Xiaoqian, et al.
Publicado: (2022)

Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8(+) T-Cell Activation
por: Wang, Zhengqi, et al.
Publicado: (2019)

Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer’s Disease Pathology
por: Zou, Fanggeng, et al.
Publicado: (2013)

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer
por: Oddo, Daniele, et al.
Publicado: (2017)

Anti-programmed cell death protein-1/ligand-1 therapy in different cancers
por: Homet Moreno, B, et al.
Publicado: (2015)

Gab Adapter Proteins as Therapeutic Targets for Hematologic Disease
por: Verma, Sheetal, et al.
Publicado: (2012)

Gab Docking Proteins in Cardiovascular Disease, Cancer, and Inflammation
por: Nakaoka, Yoshikazu, et al.
Publicado: (2013)

Epitope-Specific Mechanisms of IGF1R Inhibition by Ganitumab
por: Calzone, Frank J., et al.
Publicado: (2013)

BRAF-targeted therapy and immune responses to melanoma
por: Ngiow, Shin Foong, et al.
Publicado: (2013)

Activation of gab cluster transcription in Bacillus thuringiensis by γ-aminobutyric acid or succinic semialdehyde is mediated by the Sigma 54-dependent transcriptional activator GabR
por: Peng, Qi, et al.
Publicado: (2014)

Function, regulation and pathological roles of the Gab/DOS docking proteins
por: Wöhrle, Franziska U, et al.
Publicado: (2009)

Structure and function of Gab2 and its role in cancer (Review)
por: DING, CHEN-BO, et al.
Publicado: (2015)

Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte
por: Cicchini, Carla, et al.
Publicado: (2015)

Hepatocyte growth factor/MET in cancer progression and biomarker discovery
por: Matsumoto, Kunio, et al.
Publicado: (2017)

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation
por: Virzì, Anna Rita, et al.
Publicado: (2018)

A novel mechanism for the regulation of Gab1 recruitment to the plasma membrane
por: Eulenfeld, R, et al.
Publicado: (2009)

Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways
por: Cheng, Jianghong, et al.
Publicado: (2017)

GAB2 Amplification in Squamous Cell Lung Cancer of Non-Smokers
por: Park, Yu Rang, et al.
Publicado: (2017)

The GABA transaminase GabT is required for full virulence of Ralstonia solanacearum in tomato
por: Xian, Liu, et al.
Publicado: (2021)

GAB functions as a bioenergetic and signalling gatekeeper to control T cell inflammation
por: Kang, Siwen, et al.
Publicado: (2022)

FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors
por: Carracedo, Alma, et al.
Publicado: (2009)

Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes
por: Robert, Lidia, et al.
Publicado: (2014)

Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma
por: Lassen, Amanda, et al.
Publicado: (2014)

The Interplay between HGF/c-met Axis and Nox4 in BRAF Mutated Melanoma
por: Beretti, Francesca, et al.
Publicado: (2021)

Down-Regulation of Gab1 Inhibits Cell Proliferation and Migration in Hilar Cholangiocarcinoma
por: Sang, Haiquan, et al.
Publicado: (2013)

Targeting the Interaction between the SH3 Domain of Grb2 and Gab2
por: Malagrinò, Francesca, et al.
Publicado: (2020)

Gab2 is Essential for Transformation by FLT3-ITD in Acute Myeloid Leukemia
por: Sies, Katharina, et al.
Publicado: (2019)

Gab1 mediates PDGF signaling and is essential to oligodendrocyte differentiation and CNS myelination
por: Zhou, Liang, et al.
Publicado: (2020)

Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1
por: Chen, Hengyi, et al.
Publicado: (2020)

Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
por: Wu, Na, et al.
Publicado: (2021)

„Im Gesundheitswesen gab es bis dato keine Best-Practice-Modelle“
por: Krassnitzer, Michael
Publicado: (2022)

Hepatocyte Growth Factor/c-Met Signaling Is Required for β-Cell Regeneration
por: Alvarez-Perez, Juan Carlos, et al.
Publicado: (2014)

Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases
por: Whang, Young Mi, et al.
Publicado: (2019)

MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas
por: Schmitz, Katja, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4asvpn6mudhjh4i380h6bvd1gd